ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,968Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 6969

$982K Total Retail Price of All Prescriptions

Rank: 140 out of 6969

519 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 15,216 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ALLOPURINOL 622 599 1 35
DIOVAN 614 595 2 26
AMLODIPINE BESYLATE 601 570 3 4
AMOXICILLIN 544 488 4 99
EVISTA 543 531 5 118
METFORMIN HCL 483 471 6 7
SIMVASTATIN 436 408 7 1
LOSARTAN POTASSIUM 414 399 8 12
LIDODERM 382 367 9 75
ALENDRONATE SODIUM 365 360 10 14
FLUOCINONIDE 349 340 11 134
ATENOLOL 344 320 12 9
GABAPENTIN 283 269 13 17
GLIMEPIRIDE 277 269 14 44
HYDROCHLOROTHIAZIDE 274 261 15 8
TAMSULOSIN HCL 261 251 16 23
LEVOTHYROXINE SODIUM 212 211 17 5
NIFEDIPINE ER 204 204 18 95
DIOVAN HCT 200 198 19 57
JANUVIA 199 197 20 41
SINGULAIR 196 195 21 84
LYRICA 184 169 22 137
BENAZEPRIL HCL 182 170 23 18
CELEBREX 166 156 24 67
GEMFIBROZIL 164 133 25 85
ACTOS 155 153 26 61
CIPROFLOXACIN HCL 148 144 27 64
NEXIUM 147 140 28 52
IBUPROFEN 146 109 29 29
AMLODIPINE BESYLATE-BENAZEPRIL 141 130 30 91
OMEPRAZOLE 140 133 31 6
CLOPIDOGREL 129 126 32 48
ACTONEL 128 120 33 115
BACLOFEN 127 118 34 86
LOSARTAN-HYDROCHLOROTHIAZIDE 127 120 34 53
NAPHAZOLINE HCL 123 117 36 245
THEOPHYLLINE ANHYDROUS 117 117 37 287
FAMOTIDINE 116 108 38 37
VOLTAREN 115 114 39 105
CARVEDILOL 114 111 40 25
DONEPEZIL HCL 114 114 40 32
ISOSORBIDE MONONITRATE ER 111 105 42 81
MELOXICAM 110 106 43 36
PANTOPRAZOLE SODIUM 108 103 44 31
MONTELUKAST SODIUM 106 105 45 151
TRIAMCINOLONE ACETONIDE 105 95 46 55
GLIPIZIDE 103 98 47 21
BENICAR 102 88 48 107
METOPROLOL TARTRATE 96 85 49 13
FENOFIBRATE 91 89 50 63
AZITHROMYCIN 89 84 51 42
LIDOCAINE 88 87 52 336
ATORVASTATIN CALCIUM 88 88 52 11
ATENOLOL-CHLORTHALIDONE 86 79 54 262
MEGESTROL ACETATE 81 81 R 55 129
AVODART 79 79 56 108
ONGLYZA 78 71 57 164
CLONIDINE HCL 76 74 58 59
PLAVIX 75 75 59 68
CRESTOR 74 73 60 39
ROPINIROLE HCL 73 71 61 162
PATANOL 72 69 62 142
PROPYLTHIOURACIL 70 55 63 420
LEVOFLOXACIN 65 63 64 109
DIGOXIN 63 62 65 71
WARFARIN SODIUM 62 62 66 20
CEPHALEXIN 62 61 66 96
NAMENDA 61 61 68 51
SPIRONOLACTONE 61 61 68 102
CILOSTAZOL 58 52 70 208
ISOSORBIDE DINITRATE 57 51 71 231
HYDROXYZINE HCL 57 52 R 71 159
ADVAIR DISKUS 56 54 73 45
PROAIR HFA 55 43 74 33
LISINOPRIL 51 51 75 2
FLUTICASONE PROPIONATE 50 45 76 24
LOVASTATIN 50 44 76 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.